Table 3 Trajectories and indicators of end-of-life aggressiveness of care (n = 367 decedents)
From: First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
N | % | |
|---|---|---|
(*total number of subjects specified in the case of missing data) | (or median) | (or Q1-Q3) |
Length of survival after diagnosis of incurability (months),(*n = 361) | 11,1 | (5,2 - 22,2) |
Length of survival after first IOPC (months),(*n = 362) | 3.7 | (1,4 - 7,5) |
Index of Precocity of IOPC(*n = 349) | 0,39 | (0,16 - 0,72) |
Number of new lines of antitumoral treatment after 1st IOPC(*n = 365) | ||
0 | 203 | 55,6% |
1 | 98 | 26,8% |
≥ 2 | 64 | 17,5% |
Antitumoral treatment in the last 14 days of life(*n = 332) | 42 | 12,7% |
Location of death(*n = 367) | ||
Acute care hospital | 136 | 37,1% |
Emergency or Intensive care unit | 17 | 4,6% |
Rehabilitation unit | 10 | 2,7% |
Palliative care units | 157 | 42,8% |
Home | 29 | 7,9% |
Unknown | 18 | 4,9% |
Admission to palliative care units within 3 days of death(*n = 141) | 18 | 12,8% |